Associations of cyp1a1, gstm1 and gstt1 polymorphisms with lung cancer susceptibility in a northern indian population

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 5, 2013, Pages 3345-3349

  Shukla, R K ^a   Tilak, A R ^b   Kumar, C ^a,b   Kant, S ^a,b   Kumar, A ^b   Mittal, B ^c   Bhattacharya, S ^a,b  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^c SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

CYP1A1; Genetic polymorphism; GSTM1; GSTT1; Lung cancer; Odds ratio; Smoking

Indexed keywords

CYP1A1 PROTEIN, HUMAN; CYTOCHROME P450 1A1; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE;

CASE CONTROL STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; INDIA; LUNG TUMOR; MALE; MIDDLE AGED; QUESTIONNAIRE; SMOKING;

CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; INDIA; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; QUESTIONNAIRES; SMOKING;

EID: 84880385031     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.5.3345     Document Type: Article

References (28)

1. Bethesda M (2001). SEER Cancer Statistics Review. National Institutes of Health 1973-1998.
2. Chan-Yeung M, Tan-Un KC, Ip MS, et al (2004). Lung cancer susceptibility and polymorphisms of glutathione-Stransferase genes in Hong Kong. Lung Cancer, 45, 155-60.
3. Chen H, Sandler DP, Taylor JA, et al (1996). Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet, 347, 295-7.
4. Deutsch-Wenzel RP, Brune H, Grimmer G, Dettbarn G, Misfeld J (1983). Experimental studies in rat lungs on the carcinogenicity and dose-response relationships of eight frequently occurring environmental polycyclic aromatic hydrocarbons. J Natl Cancer Inst, 71, 539-44.
5. Gao Y, Zhang Q (1999). Polymorphisms of the GSTM1 and CYP2D6 genes associated with susceptibility to lung cancer in Chinese. Mutat Res, 444, 441-9.
6. Garte S, Boffetta P, Caporaso N, Vineis P (2001). Metabolic gene allele nomenclature. Cancer Epidemiol Biomarkers Prev, 10, 1305-6.
7. Gonzalez FJ (1990). Molecular genetics of the P-450 superfamily. Pharmacol Ther, 45, 1-38.
8. Guengerich FP, Thier R, Persmark M, et al (1995). Conjugation of carcinogens by theta class glutathione s-transferases: mechanisms and relevance to variations in human risk. Pharmacogenetics, 5, 103-7.
9. Hayes JD, Pulford DJ (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol, 30, 445-600.
10. Ingelman-Sundberg M, Oscarson M, Daly AK, Garte S, Nebert DW (2001). Human cytochrome P-450 (CYP) genes: a web page for the nomenclature of alleles. Cancer Epidemiol Biomarkers Prev, 10, 1307-8.
11. Kawajiri K, Nakachi K, Imai K, et al (1990). Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett. 263, 131-3.
12. Ketterer B, Harris JM, Talaska G, et al (1992). The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ Health Perspect, 98, 87-94.
13. Lan Q, He X, Costa DJ, et al (2000). Indoor coal combustion emissions, GSTM1 and GSTT1 genotypes, and lung cancer risk: a case-control study in Xuan Wei, China. Cancer Epidemiol Biomarkers Prev, 9, 605-8.
14. Meldrum M, Rawbone R, Curran AD, Fishwick D (2005). The role of occupation in the development of chronic obstructive pulmonary disease (COPD). Occup Environ Med, 62, 212-4.
15. Miller SA, Dykes DD, Polesky HF (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 16, 1215.
16. Mishra DK, Kumar A, Srivastava DS, Mittal RD (2004). Allelic variation of GSTT1, GSTM1 and GSTP1 genes in North Indian population. Asian Pac J Cancer Prev, 5, 362-5.
17. Naveen AT, Adithan C, Padmaja N, et al (2004). Glutathione S-transferase M1 and T1 null genotype distribution in South Indians. Eur J Clin Pharmacol, 60, 403-6.
18. Nelson HH, Wiencke JK, Christiani DC, et al (1995). Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis, 16, 1243-5.
19. Perera FP (1998). Molecular epidemiology of environmental carcinogenesis. Recent Results Cancer Res, 154, 39-46.
20. Persson I, Johansson I, Lou YC, et al (1999). Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients. Int J Cancer, 81, 325-9.
21. Raunio H, Husgafvel-Pursiainen K, Anttila S, et al (1995). Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility-a review. Gene, 159, 113-21.
22. Roy B, Majumder PP, Dey B, et al (2001). Ethnic differences in distributions of GSTM1 and GSTT1 homozygous "null" genotypes in India. Hum Biol, 73, 443-50.
23. Setiawan VW, Zhang ZF, Yu GP, et al (2000). GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population. Cancer Epidemiol Biomarkers Prev, 9, 73-80.
24. Sobti RC, Sharma S, Joshi A, Jindal SK, Janmeja A (2004). Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north indian population. Mol Cell Biochem, 266, 1-9.
25. Sørensen M, Autrup H, Tjønneland A, et al (2004). Glutathione S-transferase T1 null-genotype is associated with an increased risk of lung cancer. Int J Cancer, 110, 219-24.
26. Sreeja L, Syamala V, Hariharan S, et al (2005). Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J Hum Genet, 50, 618-27.
27. Taioli E, Ford J, Trachman J, et al (1998). Lung cancer risk and CYP1A1 genotype in African Americans. Carcinogenesis, 19, 813-7.
28. Taningher M, Malacarne D, Izzotti A, Ugolini D, Parodi S (1999). Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat Res, 436, 227-61.